Latest News and Press Releases

Innovative FemTech Device Brings UTI and Antenatal Screening into the 21st Century with Unmatched Dignity, Hygiene and Accuracy for Women and Girls

BERLIN, May 22, 2025 (GLOBE NEWSWIRE) -- Clue, the data-driven women's health intelligence platform, today announced it has reached 1 million paid subscribers, more than doubling its subscriber base...

Analysis of 2.2 million menstrual cycles shows connection between pollution exposure and reproductive health.

Clue, the most trusted, data-driven period tracking app, today announced its "Connect the Dots" campaign for Mental Health Awareness Month.

Top period tracking app, Clue, has released a survey revealing the top barriers women and people with cycles face when considering cervical screenings.

Pune, Oct. 16, 2024 (GLOBE NEWSWIRE) -- FemTech Market Size Analysis: According to SNS Insider, The FemTech Market was valued at USD 55.6 billion in 2023 and is projected to reach USD 125.35...

Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "Femtech Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Femtech Market was valued at USD 51.80...

Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "FemTech Market, By Offering, By Application, By Distribution Channel: By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for...

GAITHERSBURG, MD, May 21, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible...

GAITHERSBURG, MD, May 20, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible...